Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Peijia Medical Ltd. ( (HK:9996) ).
Peijia Medical Ltd. has announced the successful completion of the first two implants using its Trilogy Transcatheter Heart Valve System in Taiwan, China. This development marks a significant milestone in the company’s product deployment and could enhance its position in the medical device market, particularly in addressing severe aortic regurgitation and stenosis in high-risk patients.
More about Peijia Medical Ltd.
Peijia Medical Ltd. is a company incorporated in the Cayman Islands, operating in the medical device industry. It focuses on developing and marketing transcatheter heart valve systems, particularly for treating severe aortic conditions.
YTD Price Performance: -6.25%
Average Trading Volume: 524
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €310M
Find detailed analytics on 9996 stock on TipRanks’ Stock Analysis page.